Hospira Recalls Ketamine Hydrochloride Injection Due to Cracked Vials
Hospira is recalling 83,320 vials of Ketamine Hydrochloride Injection because customer complaints reported cracked and leaking glass vials.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves defective packaging (cracked/leaking vials) without reported injuries or illnesses, fitting the criteria for a moderate severity precautionary recall.
Plain-English summary
Hospira Inc. is recalling 83,320 vials of Ketamine Hydrochloride Injection, USP (100 mg/mL). The product is packaged in 5 mL multi-dose glass fliptop vials, with 10 vials per box, and is available by prescription only. The recall covers Lot #43406DD (Expiration 7/1/2016) and Lot #44255DD (Expiration 8/1/2016).
The recall was initiated due to customer complaints of cracked and leaking glass vials. The defective containers pose a risk of product loss or contamination. The affected product was distributed nationwide.
Healthcare providers and patients should stop using the recalled product and contact Hospira Inc. for further instructions or a replacement. Consumers should check their medication for the specific lot numbers and expiration dates listed above.
The recalled product
- Product
- Ketamine Hydrochloride Injection, USP (100 mg/mL) packaged in 5 mL multi-dose glass fliptop vials, 10 vials per box, Rx only, Manufactured by: Hospira Inc., Lake Forest, IL 60045. NDC 00409-2051-05
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 83,320
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #s: 43406DD
- Exp 7/1/2016
- 44255DD
- Exp 8/1/2016
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · packaging defect
See all →- HighMD Wipe Outz Numbing Tattoo Wipes Recalled for Child Poisoning Risk
CPSC · 2026-08-27
- HighV-Loc 90 Absorbable Wound Closure Devices Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- SevereDermalon Sutures Recalled for Potential Sterile Barrier Packaging Defects
FDA (Devices) · 2026-08-19
- HighV-Loc 180 Absorbable Wound Closure Device Recalled for Packaging Defects
FDA (Devices) · 2026-08-19
- HighBiopsy Forceps Recall: Sterile Packaging Breach Risk
FDA (Devices) · 2026-08-12